Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Introduction to Innate and Adaptive Immunity01:21

Introduction to Innate and Adaptive Immunity

The human immune system is a complex defense mechanism that protects the body from harmful pathogens and foreign substances. It comprises two crucial components: innate and adaptive immunity.
Innate immunity is the body's natural, nonspecific defense system that acts quickly to protect against pathogens. It incorporates physical barriers like skin and mucous membranes and cellular elements such as phagocytes and natural killer cells. This part of our immune system provides an immediate,...
What is the Immune System?01:38

What is the Immune System?

Overview
Cells of the Innate Immune Response01:28

Cells of the Innate Immune Response

The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Venetoclax in combination with a pediatric-inspired regimen for the treatment of newly diagnosed adults with Philadelphia chromosome-negative acute lymphoblastic leukemia.

Haematologica·2024
Same author

Flotetuzumab as a salvage immunotherapy in advanced CD123-positive hematological malignancies, a phase 1 pilot study.

Leukemia & lymphoma·2024
Same author

Comment on "Recent global decline of CO<sub>2</sub> fertilization effects on vegetation photosynthesis".

Science (New York, N.Y.)·2021
Same author

Ligand conjugate SAR and enhanced delivery in NHP.

Molecular therapy : the journal of the American Society of Gene Therapy·2021
Same author

siRNA rescues nonhuman primates from advanced Marburg and Ravn virus disease.

The Journal of clinical investigation·2017
Same author

Rescue of non-human primates from advanced Sudan ebolavirus infection with lipid encapsulated siRNA.

Nature microbiology·2016

Related Experiment Video

Updated: Jun 23, 2026

Using RNA-interference to Investigate the Innate Immune Response in Mouse Macrophages
12:47

Using RNA-interference to Investigate the Innate Immune Response in Mouse Macrophages

Published on: November 3, 2014

siRNA and innate immunity.

Marjorie Robbins1, Adam Judge, Ian MacLachlan

  • 1Tekmira Pharmaceuticals Corp, Burnaby, British Columbia, Canada.

Oligonucleotides
|May 16, 2009
PubMed
Summary
This summary is machine-generated.

Small interfering RNA (siRNA) can activate the mammalian innate immune system, leading to toxic side effects. Understanding and mitigating siRNA-induced immune activation is crucial for developing safe therapeutics.

More Related Videos

Stimulation of Cytoplasmic DNA Sensing Pathways In Vitro and In Vivo
11:44

Stimulation of Cytoplasmic DNA Sensing Pathways In Vitro and In Vivo

Published on: September 18, 2014

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling
09:51

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling

Published on: July 26, 2017

Related Experiment Videos

Last Updated: Jun 23, 2026

Using RNA-interference to Investigate the Innate Immune Response in Mouse Macrophages
12:47

Using RNA-interference to Investigate the Innate Immune Response in Mouse Macrophages

Published on: November 3, 2014

Stimulation of Cytoplasmic DNA Sensing Pathways In Vitro and In Vivo
11:44

Stimulation of Cytoplasmic DNA Sensing Pathways In Vitro and In Vivo

Published on: September 18, 2014

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling
09:51

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling

Published on: July 26, 2017

Area of Science:

  • Molecular Biology
  • Immunology
  • Drug Development

Background:

  • Canonical small interfering RNA (siRNA) duplexes activate the mammalian innate immune system.
  • siRNA-induced innate immunity is influenced by structure, sequence, delivery, and cell type.
  • Synthetic siRNA can trigger inflammatory cytokines and interferons via Toll-like receptor (TLR) or RIG1 pathways.

Purpose of the Study:

  • To review the mechanisms of innate immune activation by siRNA.
  • To discuss sequence design and chemical modification for reducing off-target effects.
  • To outline methods for studying siRNA-mediated immune responses.

Main Methods:

  • Review of intracellular mechanisms of siRNA innate immune activation.
  • Analysis of sequence-dependent TLR and RIG1 pathway activation.
  • Discussion of experimental approaches for evaluating siRNA effects.

Main Results:

  • siRNA-mediated immune activation is a significant concern for therapeutic development.
  • Immune activation is primarily mediated by immune cells through TLRs or non-immune cells via RIG1.
  • Sequence and chemical modifications can modulate siRNA immunogenicity.

Conclusions:

  • Abrogating siRNA-induced immune activation is essential for safe and effective siRNA therapeutics.
  • Understanding the molecular pathways involved is key to designing less immunogenic siRNA sequences.
  • Further research into experimental methods is needed to accurately assess siRNA immunogenicity.